Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.
Cyrus Biotechnology's investors include Alumni Ventures, OrbiMed, Alexandria Venture Investments, Trinity Ventures, Agent Capital.
Cyrus Biotechnology is headquartered in Seattle, United States.
Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.
Cyrus Biotechnology is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cyrus Biotechnology — Funding & Investors." VCBacked, February 26, 2024, https://www.vcbacked.co/company/cyrus-biotechnology. Accessed November 14, 2026.
VCBacked. (2024). Cyrus Biotechnology — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/cyrus-biotechnology
{{cite web |title=Cyrus Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/cyrus-biotechnology |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Cyrus Biotechnology? Request a listing update